C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 300, Issue 5, 2011, Pages

  Chima, Ranjit S ^a   LaMontagne, Timberly ^a   Piraino, Giovanna ^a   Hake, Paul W ^a   Denenberg, Alvin ^a   Zingarelli, Basilia ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lung injury; Peroxisome proliferator activated receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C PEPTIDE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROINSULIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; HEMORRHAGIC SHOCK; HYPOTENSION; IN VIVO STUDY; INSULIN SYNTHESIS; MALE; MEAN ARTERIAL PRESSURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT INFLAMMATION; RESUSCITATION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; C-PEPTIDE; CYTOKINES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUTROPHIL INFILTRATION; NF-KAPPA B; PNEUMONIA; PPAR GAMMA; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RESUSCITATION; SHOCK, HEMORRHAGIC; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955813312     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00308.2010     Document Type: Article

References (43)

1. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31: S195-S199, 2003.
2. Abraham E. NF-kappaB activation. Crit Care Med 28: N100-N104, 2000.
3. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128-5132, 1997.
4. Al-Rasheed NM, Chana RS, Baines RJ, Willars GB, Brunskill NJ. Ligand-independent activation of peroxisome proliferator-activated receptor- gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem 279: 49747-49754, 2004.
5. Al-Rasheed NM, Meakin F, Royal EL, Lewington AJ, Brown J, Willars GB, Brunskill NJ. Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47: 987-997, 2004.
6. Auten RL, Mason SN, Whorton MH, Lampe WR, Foster WM, Goldberg RN, Li B, Stamler JS, Auten KM. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med 176: 291-299, 2007.
7. Barlos D, Deitch EA, Watkins AC, Caputo FJ, Lu Q, Abungu B, Colorado I, Xu DZ, Feinman R. Trauma-hemorrhagic shock-induced pulmonary epithelial and endothelial cell injury utilizes different programmed cell death signaling pathways. Am J Physiol Lung Cell Mol Physiol 296: L404-L417, 2009.
8. Benkirane K, Amiri F, Diep QN, El Mabrouk M, Schiffrin EL. PPAR-γ inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. Am J Physiol Heart Circ Physiol 290: H390-H397, 2006.
9. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, Cochin B, Lanken PN, Leeper KV, Marini J, Murray JF, Oppenheimer L, Pesenti A, Reid L, Rinaldo J, Villar J, Vanasbeck BS, Dhainaut JF, Mancebo J, Matthay M, Meyrick B, Payen D, Perret C, Fowler AA, Schaller MD, Hudson LD, Hyers T, Knaus W, Matthay R, Pinsky M, Bone RC, Bosken C, Johanson WG, Lewandowski K, Repine J, Rodriguez-Roisin R, Roussos C, Antonelli MA, Beloucif S, Bihari D, Burchardi H, Lemaire F, Montravers P, Petty TL, Robotham J, Zapol W. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
10. Camp HS, Tafuri SR. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 272: 10811-10816, 1997.
11. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
12. Chima RS, Hake PW, Piraino G, Mangeshkar P, Denenberg A, Zingarelli B. Ciglitazone ameliorates lung inflammation by modulating the increased inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med 36: 2849-2857, 2008.
13. Chima RS, Maltese G, Lamontagne T, Piraino G, Denenberg A, O'Connor M, Zingarelli B. C-peptide ameliorates kidney injury following hemorrhagic shock. Shock 2011. EPub ahead of print.
14. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. The role of the lung in postinjury multiple organ failure. Surgery 138: 749-757; discussion 757-748, 2005.
15. Durham RM, Moran JJ, Mazuski JE, Shapiro MJ, Baue AE, Flint LM. Multiple organ failure in trauma patients. J Trauma 55: 608-616, 2003.
16. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-L1050, 2001.
17. Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR, Mitchell D, Wickersham N, Bernard GR, Matthay MA, May AK, Ware LB. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68: 1121-1127, 2010.
18. Hills CE, Brunskill NJ. Intracellular signalling by C-peptide. Exp Diabetes Res 2008: 635158, 2008.
19. Hsu JT, Kan WH, Hsieh CH, Choudhry MA, Bland KI, Chaudry IH. Role of extracellular signal-regulated protein kinase (ERK) in 17betaestradiol- mediated attenuation of lung injury after trauma-hemorrhage. Surgery 145: 226-234, 2009.
20. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277: 563-566, 1997.
21. Jarrar D, Song GY, Kuebler JF, Rue LW, Bland KI, Chaudry IH. The effect of inhibition of a major cell signaling pathway following trauma hemorrhage on hepatic injury and interleukin 6 levels. Arch Surg 139: 896-901, 2004.
22. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998.
23. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128, 1992.
24. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246, 1997.
25. Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M. Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia 51: 1534-1543, 2008.
26. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, Remacle J. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29: E21, 2001.
27. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998.
28. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, Nygren P, Stahl S, Ekberg K, Johansson B, Uhlen S, Uhlen M, Jornvall H, Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96: 13318-13323, 1999.
29. Scalia R, Coyle KM, Levine BJ, Booth G, Lefer AM. C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 14: 2357-2364, 2000.
30. Shenkar R, Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 16: 145-152, 1997.
31. Steiner DF, Cunningham D, Spigelman L, Aten B. Insulin biosynthesis: evidence for a precursor. Science 157: 697-700, 1967.
32. Tanabe Y, Koga M, Saito M, Matsunaga Y, Nakayama K. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J Cell Sci 117: 3605-3614, 2004.
33. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173: 1008-1015, 2006.
34. Vish MG, Mangeshkar P, Piraino G, Denenberg A, Hake PW, O'Connor M, Zingarelli B. Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice. Crit Care Med 35: 1348-1355, 2007.
35. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jornvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-E768, 2000.
36. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
37. Young LH, Ikeda Y, Scalia R, Lefer AM. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 279: H1453-H1459, 2000.
38. Zingarelli B. Nuclear factor-kappaB. Crit Care Med 33: S414-S416, 2005.
39. Zingarelli B, Cook JA. Peroxisome proliferator-activated receptorgamma is a new therapeutic target in sepsis and inflammation. Shock 23: 393-399, 2005.
40. Zingarelli B, Hake PW, O'Connor M, Burroughs TJ, Wong HR, Solomkin JS, Lentsch AB. Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gamma. Crit Care Med 37: 1978-1987, 2009.
41. Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR. Absence of inducible nitric oxide synthase modulates early reperfusion- induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 16: 327-342, 2002.
42. Zingarelli B, Ischiropoulos H, Salzman AL, Szabo C. Amelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat. Eur J Pharmacol 338: 55-65, 1997.
43. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook JA. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171: 6827-6837, 2003.